{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:26:10Z","timestamp":1784903170684,"version":"3.55.0"},"reference-count":191,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"University of Maryland\u2019s Center of Excellence in Regulatory Science and Innovation"},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"crossref","award":["3U01FD005946-04S3"],"award-info":[{"award-number":["3U01FD005946-04S3"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.1080\/17425255.2026.2636570","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:36:32Z","timestamp":1771677392000},"page":"139-158","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Combined oral contraceptives and pharmacokinetic drug interactions: impact on efficacy and safety"],"prefix":"10.1080","volume":"22","author":[{"given":"Sara","family":"Geriesh","sequence":"first","affiliation":[{"name":"The University of Maryland School of Pharmacy","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Kurian","sequence":"additional","affiliation":[{"name":"The University of Maryland School of Pharmacy","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Wang","sequence":"additional","affiliation":[{"name":"The University of Maryland School of Pharmacy","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2921"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.11.009"},{"key":"e_1_3_7_5_1","unstructured":"Centers for Disease Control and Prevention. Unintended pregnancy. CDC; 2024 [cited 2025 Aug 21]. Available from: https:\/\/www.cdc.gov\/reproductive-health\/hcp\/unintended-pregnancy\/index.html"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.08.002"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0000654304.29632.a7"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.057"},{"key":"e_1_3_7_9_1","volume-title":"Oral contraceptive pills","author":"Cooper DB","year":"2025","unstructured":"Cooper DB, Patel P. Oral contraceptive pills. Treasure Island (FL): StatPearls; 2025."},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2024.1395863"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.056"},{"key":"e_1_3_7_12_1","first-page":"CD002120","article-title":"Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea","volume":"4","author":"Proctor ML","year":"2001","unstructured":"Proctor ML, Roberts H, Farquhar CM. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev. 2001;4:CD002120.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746020-00003"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.122.000854"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2022.2106214"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)00418-3"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.130155097"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01716.x"},{"key":"e_1_3_7_19_1","unstructured":"Administration FaD. Clinical drug interaction studies with combined oral contraceptives: guidance for industry. 2023. Silver Spring (MD)."},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.05.019"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12745"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199108000-00012"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12499"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2689"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144791"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190015585751"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14370.1"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13581-3"},{"key":"e_1_3_7_29_1","volume-title":"Postcoital Contraception","author":"Ranganathan S","year":"2025","unstructured":"Ranganathan S, Gupta V. Postcoital Contraception. Treasure Island (FL): StatPearls; 2025."},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2016.11.006"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-9589(02)00009-7"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.07.001"},{"key":"e_1_3_7_33_1","volume-title":"Exploring QSAR - Hydrophobic, electronic, and steric constants","author":"Hansch C","year":"1995","unstructured":"Hansch C, Leo A, Hoekman D. Exploring QSAR - Hydrophobic, electronic, and steric constants. American Chemical Society; 1995."},{"key":"e_1_3_7_34_1","unstructured":"U.S. Food and Drug Administration. Label: NATAZIA (estradiol valerate and dienogest). 2024. Available from: https:\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/022252s009lbl.pdf"},{"key":"e_1_3_7_35_1","unstructured":"Human Metabolome Database (HMDB). Estradiol valerate HMDB0251966. [cited 2026 Jan 20]. Available from: https:\/\/hmdb.ca\/metabolites\/HMDB0251966"},{"key":"e_1_3_7_36_1","unstructured":"U.S. Food and Drug Administration. Label: ORTHO-CYCLEN (norgestimate\/ethinyl estradiol). 2013. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/\u2026pdf"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(89)90092-9"},{"key":"e_1_3_7_38_1","unstructured":"PubChem. PubChem annotation record for mestranol source: hazardous substances data bank (HSDB). 2004 [cited 2026 Jan 20]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/source\/hsdb\/3588"},{"key":"e_1_3_7_39_1","unstructured":"U.S. Food and Drug Administration. Label: OVCON\u00ae 35 (ethinyl estradiol\/norethindrone). 2003 [cited 2026 Jan 20]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2003\/021490lbl.pdf"},{"key":"e_1_3_7_40_1","unstructured":"U.S. Food and Drug Administration. Label: ALESSE\u00ae 28 tablets (levonorgestrel and ethinyl estradiol tablets). 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020683s012lbl.pdf"},{"key":"e_1_3_7_41_1","unstructured":"Human Metabolome Database (HMDB). Levonorgestrel (HMDB0014511). 2007 [cited 2026 Jan 20]. Available from: https:\/\/www.hmdb.ca\/metabolites\/HMDB0014511"},{"key":"e_1_3_7_42_1","unstructured":"U.S. Food and Drug Administration. Label: DESOGEN\u00ae tablets (desogestrel and ethinyl estradiol tablets USP). 2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/020071s025lbl.pdf"},{"key":"e_1_3_7_43_1","unstructured":"DrugBank. Desogestrel (DB00304). [cited 2026 Jan 20]. Available from: https:\/\/go.drugbank.com\/drugs\/DB00304"},{"key":"e_1_3_7_44_1","unstructured":"DrugBank. Dienogest (DB09123). [cited 2026 Jan 20]. Available from: https:\/\/go.drugbank.com\/drugs\/DB09123"},{"key":"e_1_3_7_45_1","unstructured":"U.S. Food and Drug Administration. Label: YAZ\u00ae (drospirenone\/ethinyl estradiol) tablets. 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021676s020lbl.pdf"},{"key":"e_1_3_7_46_1","unstructured":"Mylan Pharmaceuticals ULC. PRODUCT MONOGRAPH: drospirenone and ethinyl estradiol tablets. 2018 21. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00042999.PDF"},{"key":"e_1_3_7_47_1","unstructured":"Human Metabolome Database (HMDB). Norgestimate (HMDB0015092). 2007 [cited 2026 Jan 20]. Available from: https:\/\/www.hmdb.ca\/metabolites\/HMDB0015092"},{"issue":"9","key":"e_1_3_7_48_1","first-page":"1146","article-title":"Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months","volume":"42","author":"Dibbelt L","year":"1992","unstructured":"Dibbelt L, Knuppen R, Kuhnz W, et al. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months. Arzneimittelforschung. 1992;42(9):1146\u20131152.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_7_49_1","unstructured":"DrugBank. Gestodene (DB06730). [cited 2026 Jan 20]. Available from: https:\/\/go.drugbank.com\/drugs\/DB06730"},{"key":"e_1_3_7_50_1","unstructured":"Medscape. Estradiol. [cited 2026 Jan 20]. Available from: https:\/\/emedicine.medscape.com\/article\/2089003-overview"},{"key":"e_1_3_7_51_1","unstructured":"Medscape. Progesterone. [cited 2026 Jan 20]. Available from: https:\/\/emedicine.medscape.com\/article\/2089378-overview"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.769187"},{"issue":"2","key":"e_1_3_7_53_1","first-page":"Cd003989","article-title":"20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception","volume":"18","author":"Gallo MF","year":"2005","unstructured":"Gallo MF, Nanda K, Grimes DA, et al. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2005;18(2):Cd003989.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2011.03.001"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80067-9"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.09.058"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/17455057221147388"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi046"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-023-00249-5"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60107-1_15"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/102184"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01382.x"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04781.x"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(91)90086-K"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2024.102571"},{"issue":"3","key":"e_1_3_7_66_1","first-page":"49","article-title":"Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties","volume":"6","author":"Rubig A","year":"2003","unstructured":"Rubig A. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties. Climacteric. 2003;6(Suppl 3):49\u201354.","journal-title":"Climacteric"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107789"},{"key":"e_1_3_7_68_1","unstructured":"Preeti P Tushar B. Levonorgestrel. 2025."},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2023.2279752"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-824315-2.00049-X"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.007"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002239706"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01960-2"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102414"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(94)90018-3"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00473-0"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(94)90014-0"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.09.010"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200619"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.018"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.04.016"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1008"},{"issue":"9","key":"e_1_3_7_83_1","first-page":"927","article-title":"In vitro and in vivo metabolism of desogestrel in several species","volume":"26","author":"Verhoeven CH","year":"1998","unstructured":"Verhoeven CH, Krebbers SF, Wagenaars GN, et al. In vitro and in vivo metabolism of desogestrel in several species. Drug Metab Dispos. 1998;26(9):927\u2013936.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(91)90338-6"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)90411-1"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90552-I"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.073940"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90010-T"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(00)00133-5"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a024234"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(85)90068-8"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108459"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)13456-1"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2022.106196"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103349"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.4172\/2168-9652.1000192"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfj061"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914904107"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030194"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(90)90093-B"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb00534.x"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S460681"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(82)90064-0"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(76)90083-4"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0550351"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2007.09.025"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0260-8"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.01.010"},{"key":"e_1_3_7_109_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011419855"},{"key":"e_1_3_7_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1711-0"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-021-04338-7"},{"key":"e_1_3_7_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)37890-5"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02382.x"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03084.x"},{"key":"e_1_3_7_115_1","unstructured":"Bristol-Myers Squibb Company. Reyataz (atazanavir sulfate) capsules: prescribing information. U.S. Food and Drug Administration; 2008."},{"key":"e_1_3_7_116_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6275.1516"},{"key":"e_1_3_7_117_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.11.1299"},{"key":"e_1_3_7_118_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.045583"},{"key":"e_1_3_7_119_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.3.6"},{"key":"e_1_3_7_120_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697130500148875"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(94)00016-P"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022731"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-758-7_11"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.035030"},{"key":"e_1_3_7_125_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0331"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.017806"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.11.1266"},{"key":"e_1_3_7_128_1","unstructured":"Patel P BTLUJ. Levonorgestrel. Treasure Island (FL): StatPearls; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539737\/"},{"key":"e_1_3_7_129_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2017.1293682"},{"key":"e_1_3_7_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70196"},{"key":"e_1_3_7_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr303"},{"key":"e_1_3_7_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200110000-00011"},{"key":"e_1_3_7_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(03)00110-3"},{"key":"e_1_3_7_134_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.031526"},{"key":"e_1_3_7_135_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.040162"},{"key":"e_1_3_7_136_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212399200"},{"key":"e_1_3_7_137_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.3.610"},{"key":"e_1_3_7_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2017.11.007"},{"key":"e_1_3_7_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.08.026"},{"key":"e_1_3_7_140_1","unstructured":"Transfeminine Science. Estrogens and their influences on coagulation and risk of blood clots. 2020. Available from: https:\/\/transfemscience.org\/articles\/estrogens-blood-clots\/"},{"key":"e_1_3_7_141_1","unstructured":"Food and Drug Administration. Clinical drug interaction studies with combined oral contraceptives: guidance for industry. 2023. Silver Spring (MD)."},{"key":"e_1_3_7_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2019.06.002"},{"key":"e_1_3_7_143_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3703"},{"key":"e_1_3_7_144_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.846800"},{"key":"e_1_3_7_145_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.027854"},{"key":"e_1_3_7_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02917.x"},{"key":"e_1_3_7_147_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001302"},{"key":"e_1_3_7_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1848"},{"key":"e_1_3_7_149_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018060-00004"},{"key":"e_1_3_7_150_1","doi-asserted-by":"publisher","DOI":"10.1089\/whr.2024.0199"},{"key":"e_1_3_7_151_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.55602.x"},{"key":"e_1_3_7_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb05457.x"},{"key":"e_1_3_7_153_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03161.x"},{"key":"e_1_3_7_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(80)90102-X"},{"key":"e_1_3_7_155_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1725"},{"key":"e_1_3_7_156_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/137192"},{"key":"e_1_3_7_157_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127009803801109"},{"key":"e_1_3_7_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70138-4"},{"key":"e_1_3_7_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2004.11.004"},{"key":"e_1_3_7_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.08.009"},{"key":"e_1_3_7_161_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP44113"},{"key":"e_1_3_7_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2009.01.009"},{"key":"e_1_3_7_163_1","unstructured":"Boehringer Ingelheim. VIRAMUNE prescribing information. 2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/020636s052 020933s043lbl.pdf"},{"key":"e_1_3_7_164_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00779.x"},{"key":"e_1_3_7_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2013.02.020"},{"key":"e_1_3_7_166_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.121217"},{"key":"e_1_3_7_167_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.212494599"},{"key":"e_1_3_7_168_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746020-00003"},{"key":"e_1_3_7_169_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.000182"},{"key":"e_1_3_7_170_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.058818"},{"key":"e_1_3_7_171_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.20058"},{"key":"e_1_3_7_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.05.008"},{"key":"e_1_3_7_173_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00081.x"},{"key":"e_1_3_7_174_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr458"},{"key":"e_1_3_7_175_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.386"},{"key":"e_1_3_7_176_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.247296"},{"key":"e_1_3_7_177_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01123.x"},{"key":"e_1_3_7_178_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010088"},{"key":"e_1_3_7_179_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00749.x"},{"key":"e_1_3_7_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.08.012"},{"key":"e_1_3_7_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)15189-6"},{"key":"e_1_3_7_182_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.112240"},{"key":"e_1_3_7_183_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1073"},{"key":"e_1_3_7_184_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.70063"},{"key":"e_1_3_7_185_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb04931.x"},{"issue":"41","key":"e_1_3_7_186_1","first-page":"1451","article-title":"Enzyme induction by drugs and hormonal contraception","volume":"95","author":"Hempel E","year":"1973","unstructured":"Hempel E, Bohm W, Carol W, et al. Enzyme induction by drugs and hormonal contraception. Zentralbl Gynakol. 1973;95(41):1451\u20131457.","journal-title":"Zentralbl Gynakol"},{"key":"e_1_3_7_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90593-5"},{"key":"e_1_3_7_188_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb01773.x"},{"key":"e_1_3_7_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2020.12.002"},{"key":"e_1_3_7_190_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000344167.78102.f0"},{"key":"e_1_3_7_191_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182010607"},{"key":"e_1_3_7_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90557-N"},{"key":"e_1_3_7_193_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200212000-00013"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2026.2636570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:08:21Z","timestamp":1774530501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2026.2636570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":191,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"alternative-id":["10.1080\/17425255.2026.2636570"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2026.2636570","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}